netFormulary NHS
Lancashire and South Cumbria
Formulary
 Introduction
Welcome to the Lancashire and South Cumbria ICB Formulary

This formulary was developed with primary and secondary care clinicians with the aim of harmonising and consolidating the existing local formularies used within the region.

Please note that while some chapters have been fully reviewed by clinical groups, others were drafted in collaboration with the Formulary Working Group and have been reviewed via a consultation exercise so may be subject to change when fully reviewed. See ‘news feed’ below for more information.

Useful Links

Prescribing Guidance 

All Pathways and Guidance

Shared Care Guidelines

Place Documents

LSC Critical Care Medicines Information 

LSC ICS Proxy Ordering of Medications in Care Homes

LSC Respiratory Resources
Palliative Care Formulary PGD's: Vaccines and immunisation LSCMMG Endorsed Secondary Care Guidelines
  LSCMMG Navigation 
 LSCMMG Minutes

Change Log

Workplans

Other Information
High Cost Drugs LSCMMG Consultations LSCMMG Forms

 

Prescribers are encouraged to only prescribe medicines that are listed in formulary.   Where medicines are listed without medicinal forms or strengths, any form may be prescribed.  If a medicine is not listed, prescribers should use an equivalent listed medicine.  Professional judgement should be used when deciding on any deviations from formulary e.g. patient stabilised on a particular medicine.  Medicines that are listed as ‘do not prescribe’ should only be prescribed in exceptional circumstances.  Exceptions may arise and it is inevitable that the formulary will not include every possible use of every drug.  Clinical judgement should be used to arrive at the most reasonable outcome.  Advice and support can be taken from your local medicines optimisation team on prescribing outside of the formulary.  The formulary is applicable to new initiations and should meet the needs of the majority of patients. 

The process for Individual Funding Requests for ICB commissioned medicines is explained on the ICB web site: https://www.lancashireandsouthcumbria.icb.nhs.uk/our-work/individual-funding-requests-ifr  

The process for Individual Funding Requests for NHSE commissioned medicines is explained on the following web site:  https://www.england.nhs.uk/commissioning/spec-services/key-docs/#ifr 

Representatives from pharmaceutical companies should use the following email address: mlcsu.lscformulary@nhs.net  

Requests for updates to the formulary should be via the following email address: mlcsu.lscformulary@nhs.net

The formulary lists medicines that have been approved for use within Lancashire and South Cumbria; it employs a ‘RAG’ rating system to indicate prescribing status.  A brief summary of the RAG ratings are below: 

Green Appropriate for initiation and ongoing prescribing in both primary and secondary care.  

Green Restricted Appropriate for initiation and ongoing prescribing in both primary and secondary care provided additional criteria specific to the medicine or device are met, or the medicine is used as described the relevant LSCMMG pathway.  

Red Medicine is supplied by the hospital for the duration of the treatment course. Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances and/or a GP with specialist knowledge.  

Amber 0 Suitable for prescribing in primary care following recommendation or initiation by a specialist.  

Amber 1 Suitable for prescribing in primary care following recommendation or initiation by a specialist under a shared care agreement.  

Amber 2 Suitable for prescribing in primary care following recommendation or initiation by a specialist under a shared care agreement and enhanced service arrangements.   

Do Not Prescribe Do not prescribe: NOT recommended for use by the NHS in Lancashire and South Cumbria.   

Grey Medicines which have not yet been reviewed or are under the review process. GPs and specialists are recommended not to prescribe these drugs.  

Multiple Refer to local guidance.  

 

News Feed

June 2025:

18.06.25 - Please find below the link to download the latest change log documenting any recent formulary changes.

Netformulary change log June 25 V1


Advanced notification:

The ‘Musculoskeletal and joint diseases’ chapter will be unavailable due to updates between 4th - 6th June 25.


May 2025:

The 'Nutrition and blood' chapter is now live.


May 2025:

29.05.25 - Please find below the link to download the latest change log documenting any recent formulary changes.

Netformulary change log May 25 V1


May 2025:

The 'Palliative Care Formulary' chapter is now live.


April 2025:

25.04.25 - Please find below the link to download the latest change log documenting any recent formulary changes.

Netformulary change log April 25 V1.1


>>> more news


NetFormulary